597 related articles for article (PubMed ID: 18182324)
1. Toward cell-based therapy of type I diabetes.
Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
[TBL] [Abstract][Full Text] [Related]
2. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
[TBL] [Abstract][Full Text] [Related]
5. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
6. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
[TBL] [Abstract][Full Text] [Related]
7. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
Amer MG; Embaby AS; Karam RA; Amer MG
Gene; 2018 May; 654():87-94. PubMed ID: 29452233
[TBL] [Abstract][Full Text] [Related]
8. Animal models to study adult stem cell-derived, in vitro-generated islet implantation.
Peck AB; Yin L; Ramiya V
ILAR J; 2004; 45(3):259-67. PubMed ID: 15229373
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
Front Immunol; 2021; 12():635767. PubMed ID: 33815387
[TBL] [Abstract][Full Text] [Related]
12. Potential differentiation of islet-like cells from pregnant cow-derived placental stem cells.
Peng SY; Chou CW; Kuo YH; Shen PC; Shaw SWS
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):306-311. PubMed ID: 28600038
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation.
Sun A; Kenyon E; Gudi M; Li W; Aguirre A; Wang P
Methods Mol Biol; 2023; 2592():195-206. PubMed ID: 36507995
[TBL] [Abstract][Full Text] [Related]
14. Stem cell sources for clinical islet transplantation in type 1 diabetes: embryonic and adult stem cells.
Miszta-Lane H; Mirbolooki M; James Shapiro AM; Lakey JR
Med Hypotheses; 2006; 67(4):909-13. PubMed ID: 16762516
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk Between Immunity System Cells and Pancreas. Transformation of Stem Cells Used in the 3D Bioprinting Process as a Personalized Treatment Method for Type 1 Diabetes.
Niedźwiedzka-Rystwej P; Wołącewicz M; Cywoniuk P; Klak M; Wszoła M
Arch Immunol Ther Exp (Warsz); 2020 Apr; 68(2):13. PubMed ID: 32297019
[TBL] [Abstract][Full Text] [Related]
16. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
[TBL] [Abstract][Full Text] [Related]
17. Prevention of type 1 diabetes.
Rabinovitch A; Skyler JS
Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory properties of pancreatic islet-derived stem cells co-cultured with T cells: Does it contribute to the pathogenesis of type 1 diabetes?
Sariboyaci AE; Demircan PC; Gacar G; Unal ZS; Erman G; Karaoz E
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):179-89. PubMed ID: 25014767
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approach.
Longoni B; Mosca F
Curr Pharm Des; 2011; 17(29):3229-42. PubMed ID: 21864271
[TBL] [Abstract][Full Text] [Related]
20. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo.
Kim Y; Kim H; Ko UH; Oh Y; Lim A; Sohn JW; Shin JH; Kim H; Han YM
Sci Rep; 2016 Oct; 6():35145. PubMed ID: 27731367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
